Impact of the phytoestrogen content of laboratory animal feed on the gene expression profile of the reproductive system in the immature female rat.

The effect of the dietary background of phytoestrogens on the outcome of rodent bioassays used to identify and assess the reproductive hazard of endocrine-disrupting chemicals is controversial. Phytoestrogens, including genistein, daidzein, and coumestrol, are fairly abundant in soybeans and alfalfa, common ingredients of laboratory animal diets. These compounds are weak agonists for the estrogen receptor (ER) and, when administered at sufficient doses, elicit an estrogenic response in vivo. In this study, we assessed the potential estrogenic effects of dietary phytoestrogens at the gene expression level, together with traditional biologic end points, using estrogen-responsive tissues of the immature female rat. We compared the gene expression profile of the uterus and ovaries, as a pool, obtained using a uterotrophic assay protocol, from intact prepubertal rats fed a casein-based diet (flee from soy and alfalfa) or a regular rodent diet (Purina 5001) containing soy and alfalfa. Estrogenic potency of the phytoestrogen-containing diet was determined by analyzing uterine wet weight gain, luminal epithelial cell height, and gene expression profile in the uterus and ovaries. These were compared with the same parameters evaluated in animals exposed to a low dose of a potent ER agonist [0.1 [micro]g/kg/day 17[alpha]-ethynyl estradiol (EE) for 4 days]. Exposure to dietary phytoestrogens or to a low dose of EE did not advance vaginal opening, increase uterine wet weight, or increase luminal epithelial cell height in animals fed either diet. Although there are genes whose expression differs in animals fed the soy/alfalfa-based diet versus the casein diet, those genes are not associated with estrogenic stimulation. The expression of genes well known to be estrogen regulated, such as progesterone receptor, intestinal calcium-binding protein, and complement component 3, is not affected by consumption of the soy/alfalfa-based diet when assessed by microarray or quantitative reverse transcriptase-polymerase chain reaction analysis. Our results indicate that although diet composition has an impact on gene expression in uterus and ovaries, it does not contribute to the effects of an ER agonist. Key words: 170[alpha]-ethynyl estradiol, gene expression profiling, immature rat uterotrophic assay, microarrays, phytoestrogens, rodent diet. Environ Health Perspect 112:1519-1526 (2004). doi:10.1289/ehp.6848 available via http://dx.doi.org/[Online 16 August 2004]

**********

The effect of the dietary background of phytoestrogens on the outcome of rodent bioassays used to identify and assess the reproductive hazard of endocrine-disrupting chemicals is controversial. Phytoestrogens, including genistein, daidzein, and coumestrol, are fairly abundant in soybeans and alfalfa, common ingredients of laboratory animal diets. In fact, soy and alfalfa are commonly used as protein sources in the manufacture of most rodent diets. Some of these ingredients are kmown to contain endocrine modulators, such as the phytoestrogens genistein and daidzein (abundant in soybeans and its products) and their respective glycosides (genistin and daidzin), and coumestrol (found in alfalfa). These phytoestrogens are able to bind to both estrogen receptor (ER) isoforms, ER-[alpha] and ER-[beta], in vitro (Beck et al. 2003; Casanova et al. 1999). They have a higher affinity for ER-[beta] (Boue et al. 2003), but they activate both ER isoforms, although with less potency than estradiol. Both genistein and daidzein have much weaker affinities than does 17[beta]3-estradiol for the rat ERs: genistein binds 3- and 100fold weaker, and daidzein binds 60- and 1,000-fold weaker to rat ER-[beta] and ER-[alpha], respectively (Boue et al. 2003; Casanova et al. 1999). These two phytoestrogens are able to elicit estrogenic responses in vivo (Boettger-Tong et al. 1998; Brown and Setchell 2001; Degen et al. 2002; Jefferson et al. 2002; Levy et al. 1995; Odum et al. 2001; Thigpen et al. 1997). The selective interaction of phytoestrogens with human ER-[alpha] and ER-[beta] is similar in vitro to that described for the rat (Casanova et al. 1999; Kuiper et al. 1998).

Genistein is also known to have other activities, such as inhibition of different enzymes, among them tyrosine kinases (Akiyama et al. 1987), nitric oxide synthase (Duarte et al. 1997), and topoisomerase II (Okura et al. 1988), and decreasing calcium-channel activity in neurons (Potier and Rovira 1999). It also decreases lipid peroxidation (Arora et al. 1998) and diacylglycerol synthesis (Dean et al. 1989). Therefore, the multiple biologic activities of phytoestrogens raise the question of whether they have the potential to influence the outcome and/or interpretation of bioassays used to identify chemicals with estrogenic potential. In particular, questions have been raised about the presence of phytoestrogens in diets fed to animals used in bioassays designed to screen chemicals that may act as weak regulators of ERs and to screen low doses of potent regulators of ERs (Thigpen et al. 1997, 2002). One such bioassay is the uterotrophic and antagonists.

By using a version of the uterotrophic assay in the immature rat, one of the tier I screening assays recommended for detecting the estrogenic properties of endocrine-disrupting chemicals [Organisation for Economic Co-operation and Development (OECD) 2001; U.S. Environmental Protection Agency (U.S. EPA) 1998], we have identified a set of genes from the uterus and ovaries of prepubertal rats for which expression is regulated by estrogen exposure in a dose-dependent manner and which have the potential to be used as biomarkers for estrogen activity (Naciff et al. 2003). Gene expression changes induced by estrogen stimulation are more sensitive than the classical end points (i.e., uterine weight increase) for evaluating estrogenicity (Naciff et al. 2003). Given that components of the rodent diet commonly used in reproductive toxicology studies include chemicals with known estrogenic activity, understanding the influence of diet and dietary components on estrogen response is an important issue, in this study, we used gene expression profiling to evaluate the effect of two diets with different phytoestrogen content on the transcript profile of two organs that are responsive to estrogen stimulation: the uterus and the ovaries of prepubertal rats.

Materials and Methods

Chemicals. 17[alpha]-Ethynyl estradiol (EE) and peanut oil were obtained from Sigma Chemical Company (St. Louis, MO).

Animals and treatments. Fifteen-day-old female Sprague-Dawley rats were obtained (Charles River VAF/Plus; Charles River Laboratories, Raleigh, NC) in groups of 10 pups per surrogate mother. We chose this rat strain because it is commonly used in reproductive and developmental toxicity studies. The rats were acclimated to the local vivarium conditions (24[degrees]C; 12-hr light/12-hr dark cycle) for 5 days and were fed a casein-based diet (soy- and alfalfa-free diet; Purina 5K96, Purina Mills, St. Louis, MO). Starting on postnatal day (PND)20 and during the experimental phase of the protocol, all rats were singly housed in 20 x 32 x 20 cm plastic cages. To test the diet effect, there were two animal groups (n = 20): one group was fed a standard laboratory rodent diet (Purina 5001, Purina Mills), and the other group was maintained on the casein-based diet: The Purina 5001 diet contains phytoestrogens, mostly genistein and daidzein derived from soy and alfalfa, at levels that may have an impact on the gene expression profile (total daidzein + genistein = 0.49 mg/g; Thigpen et al. 1999), particularly in tissues regulated by estrogens such as reproductive tissues. However, those levels are not uterotrophic when evaluated by the traditional end points, uterine weight gain and increase in luminal epithelial cell height. The casein-based diet is essentially phytoestrogen free, consistently containing < 1 ppm aglycone equivalents of genistein, daidzein, and glycitein, and was fed to the four groups of animals from PND16 onward in order to remove any possible effects of the regular rodent diet (Purina 5001) previously fed to the rats by the animal supplier. All the animals were allowed free access to water and specific pelleted commercial diet (Purina 5001 or casein-based 5K96). The experimental protocol was carried out according to Procter and Gamble's animal care approved protocols, and animals were maintained in accordance with the NIH Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources 1996).

Starting on PND20, each diet group was divided into two subgroups of 10 animals. One subgroup from each diet subgroup was dosed by subcutaneous injection with 0.1 [micro]g/kg/day EE in peanut oil. This dose is not sufficient to induce a uterotrophic response in juvenile rats (Kanno et al. 2002; Naciff et al. 2003). Animals received 5 mL/kg body weight of dose solution once a day for 4 days. A 4-day dosing regime was selected to optimize detection of any effect of EE exposure at this low dose, both at the histologic level and at the gene expression level. The dose was administered between 0800 and 0900 hr each day. Controls, fed with the appropriate diet, received 5 mL/kg of peanut oil once a day for 4 days. Doses were administered on a microgram per kilogram body weight basis and adjusted daily for weight changes. Body weight (nearest 1.0 g) and the volume of the dose administered (nearest 0.1 mL) were recorded daily. The exact time of the last dose was recorded, to establish a 24-hr waiting period before tissue collection. The animals were sacrificed by C[O.sub.2] asphyxiation 24 hr after the last dosing, on PND24. The body of the uterus, cut just above its junction with the cervix, with the ovaries attached, was carefully dissected free of adhering fat and mesentery and was weighed as a whole. Then, the ovaries were dissected free, and the uterine and ovarian wet weight was recorded. Both the uterus and ovaries were placed into RNAlater (50-100 mg/mL of solution; Ambion, Austin, TX) at room temperature.

Histology. Reproductive tissues from two animals in each dose group were fixed in 10% neutral buffered formalin immediately after weighing and then dehydrated and embedded in paraffin. Serial 4-5 [micro]m cross sections were made through the ovaries, oviducts, and uterine horns, which were stained with hematoxylin and eosin. The evaluation of the morphologic changes induced by the two different diets with or without EE exposure in the uterus was performed as described previously (Naciff et al. 2003).

Expression profiling. We used 10 [micro]g total RNA, extracted from uterus and ovaries from individual animals (combining only the tissues from the same animal), to prepare biotin-labeled cRNA, as previously described (Naciff et al. 2002, 2003). Labeled cRNA samples were hybridized to the Affymetrix GeneChip Test 3 Array (Affymetrix Inc., Santa Clara, CA) to assess the overall quality of each sample. After determining the target cRNA quality, we selected individual samples of pooled uteri/ovaries from five or six individual females (replicates) from each diet group, from controls, and from EE-treated subgroups (with high quality cRNA) and hybridized them to Affymetrix Rat Genome U34A high-density oligonucleotide microarrays for 16 hr. The microarrays were washed and stained by streptavidin-phycoerythrin to detect bound cRNA. The signal intensity was amplified by second staining with biotin-labeled anti-streptavidin antibody and followed by streptavidin-phycoerythrin staining. Fluorescent images were read using the Hewlett-Packard G2500A gene array scanner (Affymetrix Inc.). Affymetrix image files for the 20 chip hybridizations, and the absolute analysis results of each diet group are available from the authors upon request.

Real-time reverse transcriptase-polymerase chain reaction. In order to corroborate the changes in gene expression identified by the oligonucleotide microarrays, we used a real-time (kinetic) quantitative reverse transcriptase-polymerase chain reaction (QRT-PCR) approach, as previously described (Naciff et al. 2002). This approach allowed us to evaluate the "basal level" of expression of individual genes in samples derived from animals exposed to the two different diets used in our study, as well as changes induced by low-dose EE exposure (0.1 [micro]g/kg/day), We compared the transcript level of selected genes in samples derived from animals in all experimental groups. To confirm the amplification specificity from each primer pair, the amplified PCR products were size-fractioned by electrophoresis in a 4% agarose gel in Tris borate ethylene diamine tetraacetic acid buffer and photographed after staining with ethidium bromide. Table 1 shows the nucleotide sequences for the primers used to test the indicated gene products. Preliminary experiments were done with each primer pair to determine the overall quality and specificity of the primer design. After QRT-PCR, we observed only the expected products at the correct molecular weight.

Data analysis. We addressed potential interindividual variability by using independent samples of each experimental group (n = 5 for each set) for analysis. For the uterine/ovarian weight determination, the luminal epithelial cell height, and the gene expression analysis, we compared the data from the animals fed with the casein-based diet with the data from the animals fed the normal rodent diet (Purina 5001). For gene expression analysis, scanned output files of Affymetrix microarrays were visually inspected for hybridization artifacts and then analyzed using Affymetrix Microarray Suite (version 5.0) and Data Mining Tool (version 3.0) software, as described by the manufacturer (Affymetrix 2002; Lockhart et al. 1996). Arrays were scaled to an average intensity of 1,500 units and analyzed independently. The Affymetrix Rat Genome U34A microarrays used in this study have 8,740 probe sets corresponding to approximately 7,000 annotated rat genes and 1,740 expressed sequence tags (ESTs).

For each transcript in the diet and dose groups, we conducted pairwise comparisons with vehicle controls fed the casein-based diet, using two-sample t-tests: first, we compared the two diet groups, and then we compared each treatment group with its respective diet control. We then conducted analysis of variance (ANOVA) for general diet and treatment effects on the signal value (which serves as a relative indicator of the level of expression of a transcript) and the log of the signal value. General diet effects were evaluated by ANOVA and a nonparametric test for dose-response trend, the Jonkheere-Terpstra test. Genes for which any of the tests had p [less than or equal to] 0.001 was taken as evidence that the expression of those genes was modified by the diet or by EE exposure. For the combined analysis of the two sets (casein-based or Purina 5001 diet), stratified nonparametric tests were conducted that were focused in detecting genes showing a diet response, or where there was a consistent treatment effect versus vehicle for the EE-treated group (0.1 [micro]g kg/day). Here, we used linear models, with terms for both study and treatment effects, on average differences (signal values) and their log transformation, as well as stratified forms of the Wilcoxon-Mann-Whitney nonparametric statistic and a stratified form of the Jonkheere-Terpstra nonparametric statistic for diet response. Fold-change summary values for genes were calculated as a signed ratio of mean signal values (for each diet and EE-treated group compared with the appropriate control). Because fold-change values can become artificially large or undefined when mean signal values approach zero, all the values < 100 were made equal to 100 before calculating the mean signal values that are used in the fold-change calculation. All statistical analyses use the measured signal values, even if they were smaller than 100 units.

Results

Effect of diet on uterine/ovarian and uterine wet weight and uterine luminal epithelial cell height. Both diets, Purina 5001 and casein-based 5K96, were well tolerated by all the animals. We observed no evidence of overt toxicity and no clinical signs of toxicity. No difference was determined in body weights between animals fed either diet (Table 2). We did not detect premature vaginal opening in any of the animals in either diet group or in animals exposed to EE. There were no differences in wet uterine weight or in absolute and relative uterine weight (Table 2) between the two diet groups, even when the animals were exposed to low doses of EE.

The gross anatomy of the uterus and ovaries of animals fed either diet was identical, and no signs of accumulation of fluid in the uterine lumen were noted in any of the animals. We observed no differences in uterine weight gain (wet weight) or uterine epithelial cell height (Figure 1), and we found no change in the number of uterine glands. The classical morphologic changes induced by estrogen stimulation (hypertrophy of luminal epithelial, stromal, and myometrial cells; thickening of stromal layer; and some stromal inflammatory reaction) were not observed in any of the animals exposed to the two different diets, even when exposed to 0.1 [micro]g kg/day EE (Figure 1).

[FIGURE 1 OMITTED]

Effect of diet on gene expression profile of the uterus/ovaries. In order to compare the gene expression profiles induced by the different diets (different phytoestrogen content) and the EE dose tested, we compared the average value of the signal values, a relative indicator of the level of expression of a transcript, between the two groups of independent controls. We then compared the appropriate diet-control group with the respective EE group (0.1 [micro]g/kg/day), for all the 8,740 transcripts represented on the array.

In comparing the expression profile identified in the uterus/ovaries of animals fed a casein-based diet versus the ones fed a soy/alfalfa-containing diet, we identified the expression of 29 genes that were significantly different (p [less than or equal to] 0.001). A list of those genes, along with their accession numbers, gene symbols, and the average fold changes, is shown in Table 3. The number of genes whose expression is modified by the diet's composition is relatively small, and the average fold change on the expression of these genes affected by the rodent standard diet, compared with the casein-based diet, is relatively low in the uterus and ovaries. Although robust expression differences for specific genes can be attributed to the composition of the diet, this list does not include genes well known to be estrogen regulated, such as progesterone receptor (PgR), intestinal calcium-binding protein (icabp), and complement component 3 (CC3).

One hypothesis is that if the soy/alfalfa-based diet was not estrogenic on its own, perhaps it would have sufficient potency to measurably enhance the effect of a sub-uterotrophic dose of EE. Although the expression of most genes from the prepubertal uterus/ovaries that respond to estrogen exposure is not altered by the diet composition, there are some that show a variable, nonstatistically significant response. For comparison, we calculated the relative fold change induced by diet for genes that showed a dear dose response to 1-10 [micro]g kg/day EE (Naciff et al. 2003). Presumably, those genes have the potential to represent the response to weak or low levels of estrogen stimulation (expected from the dietary phytoestrogens) and are shown in Table 4, The fold change represents the ratio of the relative expression level of each gene in tissues from animals fed Purina 5001 versus those fed the 5K96 diet (as indicated in Table 3). For comparison, in Table 4 the relative expression level of the same transcripts under EE exposure is also shown. Analyzing the effect of EE exposure on the expression of the same set of genes, comparing the relative expression level of each gene in the tissues from animals exposed to EE versus their respective controls that were fed the same diet, and taking into account that lack of statistical significance for those genes listed, the average (n = 5) response to EE exposure is very similar, if not equal, even for those showing a relative large fold change, regardless of the diet fed to the animals. These results suggest that the response to the diet's composition is independent from the EE effect at this dose level of exposure. At higher doses of EE, the contribution of the dietary phytoestrogens is considered negligible because EE is a potent ER agonist able to interact with both isoforms of this receptor and with higher affinity than any of the dietary phytoestrogens (Kuiper et al. 1997). The changes induced by exposure to higher EE doses have been reported (Naciff et al. 2003). Corroboration of the microarray results by QRT-PCR for a selected group of genes is shown in Table 5. With the exception of CC3, which is undetectable by microarray analysis of samples derived from the animals exposed to two different diets (Table 5), the expression levels of the other genes are very similar, determined by either QRT-PCR or microarray analysis.

Discussion

Dietary phytoestrogens, such as genistein and daidzein (abundant in soybeans and its products) and their respective glycosides (genistin and daidzin), and coumestrol (found in alfalfa), have been found to have estrogenic properties in both in vitro and in vivo (Beck et al. 2003; Boettger-Tong et al. 1998; Boue et al. 2003; Brown and Setchell 2001; Casanova et al. 1999; Degen et al. 2002; Jefferson et al. 2002; Kanno et al. 2002; Levy et al. 1995; Odum et al. 2001; Thigpen et al. 2002). However, the results of the present study showed that phytoestrogens at concentrations present in a given lot of a commercial rodent diet are not able to elicit an estrogenic response in the reproductive system of the immature rat, judged by classical end points and specific gene expression changes characteristic of estrogen exposure in estrogen-responsive target organs (uterus and ovaries). Although a number of gene expression differences were observed with the two rodent diets tested, Purina 5001 and casein-based diet (relatively high vs. low phytoestrogen content, respectively), they cannot be correlated with estrogenic activity. These gene expression changes are more likely to be caused by nutritional differences between the diets, rather than individual dietary components affecting ER pathways. Also, the traditional end points used to assess estrogenic activity, namely, uterine wet weight gain and hypertrophy of luminal epithelial cell layer, were not affected by the phytoestrogen content of the diet. It has to be stressed that we have previously identified gene expression as being far more sensitive than the classical uterotrophic response in assessing estrogenicity (Naciff et al. 2003).

We also tested whether the consumption of phytoestrogen-containing diets was sufficient to render a subuterotrophic dose regimen of EE active. To do this, we evaluated the number and type of genes whose expression is modified in the uterus/ovaries from animals exposed to 0.1 [micro]g/kg/day EE but fed different diets. There is not a statistically different number of genes affected by components of the diet, and those genes affected by EE are the same, regardless of the diet fed to the animals. More important, the different phytoestrogen content of the diets does not modify--by either increasing or decreasing--the response of the estrogen-sensitive genes from the uterus/ovaries to low doses of a potent ER agonist; their expression changes in the same direction and magnitude as a result of EE regardless of whether the rats were fed the phytoestrogen-containing diet. Table 4 shows the transcripts that we have previously identified as being responsive to estrogen exposure, under the uterotrophic assay protocol (Naciff et al. 2003), with their relative expression level calculated by comparing the two diets. This includes genes that have an extremely robust response to estrogen exposure, such as CC3, PgR, and icabp (Heikaus et al. 2002; Krisinger et al. 1992; L'Horset et al. 1990; Li et al. 2002; Naciff et al. 2003). Thus, we are confident that, despite the potential effect of the phytoestrogens in the Purina 5001 diet, the transcript profile determined in the uterus and ovaries is comparable with the one determined in the animals fed the casein-based diet, and truly reflects the lack of estrogenic activity of the soy/alfalfa-based diet.

Our data corroborate the findings of the OECD (Owens et al. 2003), Wade et al. (2003), and Yamasaki et al. (2002) in the uterotrophic assay. As part of the studies conducted by the OECD validation initiative, it has been established that the phytoestrogen contents of the multiple rodent diets employed by the participant laboratories had no important effect on the sensitivity of the uterotrophic assay (Owens et al. 2003). In independent studies, Wade et al. (2003) and Yamasaki et al. (2002) reached the same conclusions by testing the effect of various phytoestrogen-containing diets in the outcome of their immature uterotrophic assays. Our findings also agree with reports on the effects of phytoestrogens on the reproductive system of other species. Foth and Cline (1998) reported that supplementing the diet of postmenopausal macaques with up to 148 mg of phytoestrogen (from soy) per day for 6 months failed to induce any proliferative effects on endometrial histology, a marker for estrogenic stimulation. Anthony et al. (1996) determined that dietary soybean isoflavones improve cardiovascular risk factors (plasma lipids, lipoproteins, and atherosclerosis) without detectable estrogenic effects in the reproductive system of peripubertal rhesus monkeys. The data presented here establish the fact that the phytoestrogens found in a regular Western diet (compared with traditional Asian diets), exemplified here as the standard rodent diet, do not elicit an estrogenic response at the histologic level or at the gene expression level. Thus, the potential benefits for humans derived from consuming a normal diet (not intentionally enriched with phytoestrogens) are not compromised by undesired estrogenic properties.

These findings demonstrate that the phytoestrogens present in a regular rodent diet do not affect the biologic response to a potent exogenous ER agonist, at the level of tissue architecture or gene expression, in prepubertal rat uterus and ovaries. From the results of the present study, it is clear that in order to elicit an estrogenic response at the gene expression level, the organism has to be exposed to higher concentrations of phytoestrogens, as has been shown in the developing female rat with pure genistein (Jefferson et al. 2002; Naciff et al. 2002). It must be stressed that the route of administration has an impact on the degree of the response; Ashby (2000) has shown that genistein gives a stronger uterotrophic response in the immature mouse when subcutaneously injected than when given orally at equivalent concentrations.

Some of the gene expression changes attributed to the composition of the diet, determined in the present study, may have an impact on the biologic response of the reproductive system (uterus/ovaries), mostly by influencing various pathways, some of which have an effect on sex hormone axis. However, none of these genes was included in the transcript profile determined for estrogens in the immature rat uterus and ovaries (Naciff et al. 2003). For example, rGrb14, the rat homologue of the human growth factor receptor, bound human Grb14 adaptor protein, a direct inhibitor of the activated insulin receptor (Bereziat et al. 2002; Kasus-Jacobi et al. 1998), whose up-regulation may result in modification of the response of the uterus/ovaries to insulin. Another gene whose expression is modified by the composition of the diet is that of the gonadotropin-releasing hormone receptor, which among other activities regulates gametogenic and hormonal functions of the gonads (Kang et al. 2003). The expression of insulin-like growth factor 1 (IGF-1) is up-regulated in the reproductive tissues of animals fed the diet with a relatively high phytoestrogen content (Table 3). IGF-1 is a critical regulator of uterine growth, and locally produced uterine IGF-1 could mediate the effects of estradiol on growth and cellular proliferation (Sato et al. 2002). The expression of the gene encoding steroid 3-[alpha]-dehydrogenase is also up-regulated by the soy/alfalfa-based diet. This enzyme, a member of the aldo-keto reductase gene superfamily, is an important multifunctional oxidoreductase capable of metabolizing steroid hormones, polycyclic aromatic hydrocarbons, and prostaglandins (Huang and Luu-The 2000). Aquaporin 1 (AQP1) is one of the genes for which expression is down-regulated by a soy/alfalfa-based diet. This gene encodes a protein that is a member of a family of membrane channel proteins which facilitate bulk water transport and possibly other small molecules, the aquaporins. Treatment of adult ovariectomized mice with replacement steroids demonstrates an estrogen-induced shift in AQP1 signals from the myometrium to the uterine stromal vasculature, suggesting a role in uterine fluid inhibition (Richard et al. 2003), one of the physiologic responses of the uterus to estrogen stimulation. However, the relative expression level of AQP1 gene was not determined by Richard et al. (2003). Li et al. (1997) described a stimulatory effect of estradiol at relatively high concentrations (40 [micro]g/kg) in the expression level of an aquaporin gene (AQP-CHIP) in the uterus of immature rats, although this gene was not identified as AQP1. However, the response of AQP1 in the immature uterus of the rat to dietary components is actually a decrease in its expression level, opposite the effect of estrogenic stimulation.

In all, our data indicate that although there is a clear effect of the diet of the gene expression profile of the uterus/ovaries from the immature rats, this effect is subtle and cannot be correlated with the phytoestrogen content of each diet. Most of the gene transcripts represented in the microarray used in this study have an expression level that is very similar in all the animals, regardless of their diet. Further, by analyzing the expression levels of known estrogen-regulated genes (Naciff et al. 2003), we determined that there is not a significant difference in the relative expression level of any of those genes between animals exposed to Purina 5001 or casein-based diets. [n addition, we found no significant changes at the transcript level for selected estrogen-regulated genes by QRT-PCR. Thus, we are confident that--despite the potential effect of the phytoestrogens in the diet of animals used in a bioassay designed to evaluate the potential estrogenic activity of a given chemical--the response to the chemical (which could be the transcript profile induced by exposure) is independent of the diet and has the potential to truly reflect estrogenic activity.

Table 1. Primers used to verify the array-based gene expression
changes induced by the two different diets, by QRT-PCR.

                                  GenBank
                                 accession
Gene name                         no. (a)          Forward primer

Complement component 3 (CC3)     M29866      5'-CGTGAGCAGCACAGAAGAGA-3'
Progesterone receptor (PgR)      L16922      5'-CATGTCAGTGGACAGATGCT-3'
Intestinal calcium-binding
  protein (icabp)                K00994      5'-ATCCAAACCAGCTGTCCAAG-3'
11-[beta]-Hydroxylsteroid
  dehydrogenase type 2
  (11[beta]HSD)                  U22424      5'-ATGGCATTGCCTGACCTTAG-3'
Vascular [alpha]-actin
  (VaACTIN)                      X06801      5'-GACACCAGGGAGTGATGGTT-3'
Cyclophilin B                    AF071225    5'-CAAGCCACTGAAGGATGTCA-3'
Cytochrome P450 subfamily XVII   M21208      5'-AAGTGGATCCTGGCTTTCCT-3'
  (Cyp17)
AA924771 EST Rattus norvegicus   AA924772    5'-TTTGCTGTGCATGGGATTTA-3'

                                                              Amplicon
Gene name                              Reverse primer         size (bp)

Complement component 3 (CC3)     5'-CCAGGTGGTGATGGAATCTT-3'      204
Progesterone receptor (PgR)      5'-ACTTCAGACATCATTTCCGG-3'      428
Intestinal calcium-binding
  protein (icabp)                5'-TGTCGGAGCTCCTTCTTCTG-3'      196
11-[beta]-Hydroxylsteroid
  dehydrogenase type 2
  (11[beta]HSD)                  5'-CTCAGTGCTCGGGGTAGAAG-3'      194
Vascular [alpha]-actin
  (VaACTIN)                      5'-GTTAGCAAGGTCGGATGCTC-3'      202
Cyclophilin B                    5'-AAAATCAGGCCTGTGGAATG-3'      239
Cytochrome P450 subfamily XVII   5'-CAATGCTGGAGTCGACGTTA-3'      211
  (Cyp17)
AA924771 EST Rattus norvegicus   5'-CCCTGCAGGATGTGAGAAGT-3'      202

(a) From GenBank (2004).

Table 2. Diet effect on body, uterine, and ovarian weight and
luminal epithelial cell height of the juvenile (PND24) rat.

                                       Casein-based diet (5K96)

                                      Body               Ovarian
                                     weight               weight
                                       (g)                 (mg)

Peanut oil
  Mean [+ or -] SD (absolute)   68.1 [+ or -] 4.8   32.0 [+ or -] 2.6
  Mean [+ or -] SD (relative)
    (a)                                             0.50 [+ or -] 0.04
  p-Value (b)
0.1 EE ([micro]g/kg/day)
  Mean [+ or -] SD (absolute)   68.5 [+ or -] 5.4   36.2 [+ or -] 2.1
  Mean [+ or -] SD (relative)
    (a)                                             0+52 [+ or -] 0.1
  p-Value (b)

                                         Casein-based diet (5K96)

                                     Uterine          Epithelial cell
                                      weight              height
                                       (mg)             ([micro]m)

Peanut oil
  Mean [+ or -] SD (absolute)   56.1 [+ or -] 8.2    13.3 [+ or -] 1.3
  Mean [+ or -] SD (relative)
    (a)                         0.58 [+ or -] 0.04
  p-Value (b)
0.1 EE ([micro]g/kg/day)
  Mean [+ or -] SD (absolute)   61.9 [+ or -] 11.2   13.1 [+ or -] 1.6
  Mean [+ or -] SD (relative)
    (a)                         0.93 [+ or -] 0.1
  p-Value (b)

                                           Purina 5001 diet

                                      Body               Ovarian
                                     weight               weight
                                       (g)                 (mg)

Peanut oil
  Mean [+ or -] SD (absolute)   70.1 [+ or -] 4.9   34.8 [+ or -] 3.3
  Mean [+ or -] SD (relative)
    (a)                                             0.49 [+ or -] 0.07
  p-Value (b)                         0.05                 0.18
0.1 EE ([micro]g/kg/day)
  Mean [+ or -] SD (absolute)   71.1 [+ or -] 5.8   37.1 [+ or -] 1.8
  Mean [+ or -] SD (relative)
    (a)                                             0.52 [+ or -] 0.1
  p-Value (b)                         0.05                 0.14

                                            Purina 5001 diet

                                     Uterine          Epithelial cell
                                      weight              height
                                       (mg)             ([micro]m)

Peanut oil
  Mean [+ or -] SD (absolute)   59.6 [+ or -] 10.8   14.0 [+ or -] 2.2
  Mean [+ or -] SD (relative)
    (a)                         0.56 [+ or -] 0.08
  p-Value (b)                          0.41                0.26
0.1 EE ([micro]g/kg/day)
  Mean [+ or -] SD (absolute)   66.4 [+ or -] 13.2   14.5 [+ or -] 1.3
  Mean [+ or -] SD (relative)
    (a)                         0.93 [+ or -] 0.2
  p-Value (b)                          0.36                0.18

During the experimental phase, PND20 female rats were fed with a
standard laboratory rodent diet (Purina 5001) or with a soy- and
alfalfa-free diet (casein-based diet, 5K96) for 5 days (from
PND20 to PND24). Epithelial cell height values were obtained from
tissue sections from the midregion of each uterine horn, at
equivalent areas, and with clear representation of the epithelium
lining the lumen along the uterus (as shown in Figure 1).
Epithelial cell height was determined by obtaining five
measurements from five areas from two animals for each group.
These values were used to determine the mean cell height SD for
each treatment group, and the corresponding p-value.

(a) Relative weight (mg/g body weight). (b) Two-tailed t-test
comparing 5K96 with Purina 5001, in control or treated animals;
n = 15 for each diet group (controls) and n = 10 for EE-treated
groups.

Table 3. Genes whose expression is modified by exposure
to diet in the uterus/ovaries of the immature rat.

GenBank
accession                                                        Gene
no. (a)                         Gene name                       symbol

X67948      Aquaporin 1 (aquaporin channel forming integral
              protein)                                          AQP1
U56839      Purinergic receptor P2Y, G-protein coupled 2        P2ry2
AF017756    GSK-3beta interacting protein rAxin                 Axin
AA859529    Diacylglycerol acyltransferase                      Dgat
L06096      Inositol 1,4,5-triphosphate receptor 3              Itpr3
U90887      Arginase type II                                    Arg2
U78977      ATPase, class II, type 9A                           Atp9a
AA892562    EST196365, high homology to nucleolar protein
              NAP57 and dyskeratosis congenita 1, dyskerin      Dkc1
AI639534    ESTs, similar to properdin (factor P)
AI231213    ESTs, high homology to kangai 1 (suppression of
              tumorigenicity 6), prostate                       Kai1
D10874      Vacuolar H(+)-transporting ATPase,
X56133      Mitochondrial H+-ATP synthase alpha subunit         Atp5a1
D13417      Transcription factor HES-1 homolog of hairy and
              enhancer of split 1, (Drosophila)                 Hes1
Z71925      Polymerase (RNA) II (DNA directed) polypeptide G    Polr2g
AA818487    ESTs, high homology to cyclophilin B                Ppib
AI112237    ESTs, moderately similar to JE0384 NADH
              dehydrogenase
AA818858    Peptidylprolyl isomerase A (cyclophilin A)          Ppia
AA686579    ESTs, similar to ubiquitin-like protein SMT3C
              precursor
U64705      Protein synthesis initiation factor 4All gene and
              E3 small nucleolar RNA gene
S69316      GRP94/endoplasmin (5 and 3 regions)
M15481      Insulin-like growth factor 1                        IGF-1
S69315      GRP94/endoplasmin (5 and 3 regions)
D17310      3-alpha-Hydroxysteroid dehydrogenase(3-alpha-HSD)
X67859      Autoantigen or Sjogren syndrome antigen B           Ssb
AA685903    ESTs, similar to glucose regulated protein, 94
              kDa                                               GRP94
S68578      Gonadotropin-releasing hormone receptor             Grhr
AI009141    EST203592, Rattus norvegicus
AF076619    Growth factor receptor bound protein 14 or
              molecular adapter rGrb14 (Grb14), an inhibitor
              of insulin actions                                Grb14

                                                    Average
                                                     fold
                                                    change    p-Values
                    Gene name                         (b)       (c)

Aquaporin 1 (aquaporin channel forming integral
  protein)                                            1.6     0.000159
Purinergic receptor P2Y, G-protein coupled 2          1.4     0.000448
GSK-3beta interacting protein rAxin                   1.4     0.000130
Diacylglycerol acyltransferase                        1.3     0.000470
Inositol 1,4,5-triphosphate receptor 3                1.3     0.000420
Arginase type II                                      1.3     0.000728
ATPase, class II, type 9A                             1.3     0.000022
EST196365, high homology to nucleolar protein
  NAP57 and dyskeratosis congenita 1, dyskerin        1.3     0.000747
ESTs, similar to properdin (factor P)                 1.3     0.000446
ESTs, high homology to kangai 1 (suppression of
  tumorigenicity 6), prostate                         1.2     0.000561
Vacuolar H(+)-transporting ATPase,                    1.2     0.000865
Mitochondrial H+-ATP synthase alpha subunit          -1.1     0.000854
Transcription factor HES-1 homolog of hairy and
  enhancer of split 1, (Drosophila)                  -1.2     0.000045
Polymerase (RNA) II (DNA directed) polypeptide G     -1.2     0.000379
ESTs, high homology to cyclophilin B                 -1.2     0.000253
ESTs, moderately similar to JE0384 NADH
  dehydrogenase                                      -1.2     0.000192
Peptidylprolyl isomerase A (cyclophilin A)           -1.3     0.000943
ESTs, similar to ubiquitin-like protein SMT3C
  precursor                                          -1.3     0.000954
Protein synthesis initiation factor 4All gene and
  E3 small nucleolar RNA gene                        -1.3     0.000405
GRP94/endoplasmin (5 and 3 regions)                  -1.3     0.000120
Insulin-like growth factor 1                         -1.3     0.000068
GRP94/endoplasmin (5 and 3 regions)                  -1.4     0.000174
3-alpha-Hydroxysteroid dehydrogenase(3-alpha-HSD)    -1.4     0.000397
Autoantigen or Sjogren syndrome antigen B            -1.4     0.000103
ESTs, similar to glucose regulated protein, 94
  kDa                                                -1.5     0.000878
Gonadotropin-releasing hormone receptor              -1.5     0.000322
EST203592, Rattus norvegicus                         -1.8     0.000468
Growth factor receptor bound protein 14 or
  molecular adapter rGrb14 (Grb14), an inhibitor
  of insulin actions                                 -2.1     0.000158

(a) From GenBank (2004). (b) The average fold change was determined
by comparing the average signal value of the indicated transcripts
obtained from the uterus/ovaries from five females fed with the
casein-based diet (5K96) versus the average signal value obtained
from the same tissues from five females fed the standard rodent diet
(Purina 5001). (c) Transcripts listed are those showing a robust
response to the different diet (p < 0.001) using the stratified form
of the Jonkheere-Terpstra nonparametric statistic to identify the
diet response.

Table 4. Diet effect on genes whose expression is modified
by exposure to of 0.1 [micro]g/kg EE in the uterus/ovaries
of the immature rat.

GenBank
accession                                           Gene
no. (a)                  Gene name                 symbol

M29866      Complement component 3                 CC3
Y08358      Eotaxin or small inducible cytokine
              A11                                  Scya11
AI013389    ESTs, similar to calcium-binding
              protein, intestinal, vitamin
              D-dependent                          Calb3
K00994      Intestinal calcium-binding protein     icabp
U49062      CD24 antigen                           Cd24
L14004      Polymeric immunoglobulin receptor      pigr
AA859661    ESTs, similar to glutaminyl-peptide
              cyclotransferase precursor
M57718      Cytochrome P450 IV A1                  CYP4A1
U22424      Hydroxysteroid dehydrogenase,
              11-[beta] type 2                     Hsd11b2
L07114      Apolipoprotein B editing protein       Apobec1
S79730      Opioid receptor-like ORL1 receptor     Oprl1
M88469      f-Spondin                              Sponf
X66845      Dynein, cytoplasmic, intermediate
              chain 1                              Dncic1
L46593      Small proline-rich protein gene        Sprr
L00191      Fibronectin, encoding three mRNAs,
              exons 1, 2, 3                        fn
M22323      Gamma-enteric smooth muscle actin      Actg2
D15069      Adrenomedullin                         Adm
AA893870    EST197673 Rattus norvegicus
AI232078    Transforming growth factor-[beta]
              (TGF-[beta]) masking protein         Ltbp1
U82612      Fibronectin (fn-1) gene                fn-1
X05834      Fibronectin (fn-3) gene                fn-3
L00382      Skeletal muscle [beta]-tropomyosin
              and fibroblast tropomyosin 1         tpm1
AA800908    EST190405 Rattus norvegicus
M25758      Phosphatidylinositol transfer
              protein                              Pitpn
AA799773    ESTs, Rattus norvegicus
AA892829    EST, similar to mouse bifunctional
              3'-phosphoadenosine (PPS1)           PPS1
AB010963    Potassium large conductance
              calcium-activated channel            Kcnmb1
AF083269    Actin-related protein complex 1b       Arpc1b
AA891760    EST195563 Rattus norvegicus
AJ005394    Collagen [alpha] 1 type V              Col5a1
L11930      Cyclase-associated protein homologue   Cap1
X07467      Glucose-6-phosphate dehydrogenase      G6pd
U26310      Tensin                                 Tns
AA891542    EST195345 Rattus norvegicus, similar
              to mouse heat shock protein
              hsp40-3                              Dnajb5
U44948      Cysteine-rich protein 2 or smooth
              muscle cell LIM protein (SmLIM)      Csrp2
S61868      Ryudocan or heparan sulfate
              proteoglycan core protein or
              syndecan-4                           SDC4
L41254      Corticosteroid-induced protein or
              FXYD domain-containing ion
              transport regulator 4                Fxyd4
AF023087    Nerve growth factor induced factor
              A, or early growth response 1        Egr1
U07181      Lactate dehydrogenase B                Ldhb
X89225      Solute carrier family 3, member 2      Slc3a2
AF054826    Vesicle-associated membrane
              protein 5                            Vamp5
X75253      Phosphatidylethanolamine binding
              protein                              Pbp
AA924772    ESTs, similar to metallothionein 3     Mt3
AA894027    EST197830 Rattus norvegicus
AA894030    EST197833 Rattus norvegicus
AA946532    ESTs, similar to ATP-binding
              cassette, sub-family D (ALD),
              member 3                             Abcd3
M32754      Inhibin [alpha]-subunit                Inha
AA874794    ESTs, similar to nerve growth factor
              receptor (TNFRSF16) associated
              protein 1                            Ngfrap1
M21060      Superoxide dismutase 1, soluble        Sod1
X08056      Guanidinoacetate methyltransferase     GAMT
D00729      [delta]3, [delta]2-enoyl-CoA
              isomerase
U90829      APP-binding protein 1                  Appbp1
AI170613    ESTs, similar to heat shock 10 kDa
              protein 1                            Hspe1
D63761      Adrenodoxin reductase                  Fdxr
D78303      Splicing factor YT521-B                YT521
L48060      Prolactin receptor                     Prlr
AA849036    ESTs, similar to guanylate cyclase     Gucy1a3
              1, soluble, [alpha]-3
M33648      Mitochondrial 3-hydroxy-3-
              methylglutaryl-CoA synthase          HMGCS2
E05646      Phosphatidylethanolamine binding
              protein                              Pbp
AA858520    ESTs, similar to follistatin           Fst
L02842      Follicle-stimulating hormone
              receptor                             FSHR
X04229      Glutathione-S-transferase, [mu]
              type 1 (Yb1)                         Gstm1
L23148      Inhibitor of DNA binding 1,
              helix-loop-helix protein             Id1
D63761      Adrenodoxin reductase                  Fdxr
AF076619    Growth factor receptor bound protein
              14                                   Grb14
M33648      Mitochondrial 3-hydroxy-3-
              methylglutaryl-CoA synthase
AA858520    Follistatin                            Fst
X62660      Glutathione transferase subunit 8
AI175776    FST219344 Rattus norvegicus
J03914      Glutathione-S-transferase, [mu] type
              2 (Yb2)                              Gstm2
J02592      Glutathione-S-transferase, [mu] type
               2 (Yb2)                             Gstm2
S59525      Gonadotropin-releasing hormone
              receptor                             grhr
M36453      Inhibin [alpha]                        Inha
X54793      Heat shock protein 60 (liver)          Hsp60
AA858640    ESTs
L19998      Minoxidil sulfotransferase             PST-1
X78848      Glutathione-S-transferase, [alpha]
              type (Ya)                            Gsta1
AF001898    Aldehyde dehydrogenase 1, subfamily
              A1                                   Aldh1a1
X97754      Hydroxysteroid dehydrogenase
              17[beta] type 1                      Hsd17b1
AF000942    Inhibitor of DNA binding 3, dominant
              negative helix-loop-helix            Id3
AI171268    EST217223 Rattus norvegicus,
              identical to inhibitor of DNA
              binding 3, dominant negative
              helix-loop-helix                     Id3
D84336      Delta-like homolog (Drosophila), a
              novel member of the epidermal
              growth factor (EGF)-like family of
              proteins                             Dlk1
S63167      3 [beta]-Hydroxysteroid
              dehydrogenase isomerase type II      HSD3R2
M12492      Type II cAMP-dependent protein
              kinase regulatory subunit            prkar2a
S72505      Glutathione S-transferase Yc1
              subunit
AA874919    Mismatch repair protein                Msh2
M14656      Sialoprotein (osteopontin)             Spp1
X01115      SVS-protein F, or seminal vesicle
              secretion 5                          Svs5
M21208      Cytochrome P450, subfamily XVII        Cyp17

                                           Average told change (b)

                                                              EE vs.
                                                   EE vs.     control,
                                        Purina     control,   Purina
             Gene name                 5001/5K96    5K96        5001

Complement component 3                     A         14.7       7.0
Eotaxin or small inducible cytokine
  A11                                      A          2.7       2.9
ESTs, similar to calcium-binding
  protein, intestinal, vitamin
  D-dependent                             2.0         2.4       1.9
Intestinal calcium-binding protein        1.1         5.2       2.1
CD24 antigen                              1.1         1.3       1.2
Polymeric immunoglobulin receptor         1.5         1.4       1.1
ESTs, similar to glutaminyl-peptide
  cyclotransferase precursor               A          2.1       1.7
Cytochrome P450 IV A1                      A          A          A
Hydroxysteroid dehydrogenase,
  11-[beta] type 2                        1.0         2.2       1.6
Apolipoprotein B editing protein           A          A          A
Opioid receptor-like ORL1 receptor        1.2         1.3       1.4
f-Spondin                                 1.7         1.7       1.1
Dynein, cytoplasmic, intermediate
  chain 1                                  A          A          A
Small proline-rich protein gene           2.4         2.5      -1.0
Fibronectin, encoding three mRNAs,
  exons 1, 2, 3                          -1.2         1.6       1.2
Gamma-enteric smooth muscle actin         1.4         1.5       1.3
Adrenomedullin                            1.9         2.4       1.2
EST197673 Rattus norvegicus                A          1.7       2.0
Transforming growth factor-[beta]
  (TGF-[beta]) masking protein           -1.1         1.2       1.1
Fibronectin (fn-1) gene                   1.5         1.6       1.1
Fibronectin (fn-3) gene                   1.0         1.4       1.2
Skeletal muscle [beta]-tropomyosin
  and fibroblast tropomyosin 1            1.2         1.7       1.3
EST190405 Rattus norvegicus               1.2         1.6       1.4
Phosphatidylinositol transfer
  protein                                 1.1         1.3       1.3
ESTs, Rattus norvegicus                   1.3         1.3       1.2
EST, similar to mouse bifunctional
  3'-phosphoadenosine (PPS1)              1.2         1.3       1.1
Potassium large conductance
  calcium-activated channel               1.2         1.4       1.2
Actin-related protein complex 1b          1.0         1.3      -1.0
EST195563 Rattus norvegicus                A          A          A
Collagen [alpha] 1 type V                -1.1         1.6       1.2
Cyclase-associated protein homologue      1.1         1.3       1.2
Glucose-6-phosphate dehydrogenase         1.2         1.2      -1.1
Tensin                                    1.2         1.3       1.1
EST195345 Rattus norvegicus, similar
  to mouse heat shock protein
  hsp40-3                                 1.3         1.3       1.1
Cysteine-rich protein 2 or smooth
  muscle cell LIM protein (SmLIM)        -1.1        -1.6      -1.4
Ryudocan or heparan sulfate
  proteoglycan core protein or
  syndecan-4                             -1.2        -1.5      -1.1
Corticosteroid-induced protein or
  FXYD domain-containing ion
  transport regulator 4                  -1.1        -1.4      -1.1
Nerve growth factor induced factor
  A, or early growth response 1          -1.5        -1.7       1.1
Lactate dehydrogenase B                  -1.3        -1.2      -1.1
Solute carrier family 3, member 2        -1.3        -1.5      -1.3
Vesicle-associated membrane
  protein 5                              -1.2        -1.8      -1.2
Phosphatidylethanolamine binding
  protein                                -1.2        -1.4      -1.1
ESTs, similar to metallothionein 3         A          A          A
EST197830 Rattus norvegicus                A          A          A
EST197833 Rattus norvegicus                A          A          A
ESTs, similar to ATP-binding
  cassette, sub-family D (ALD),
  member 3                               -1.3        -1.4      -1.3
Inhibin [alpha]-subunit                  -1.3        -1.6       1.0
ESTs, similar to nerve growth factor
  receptor (TNFRSF16) associated
  protein 1                               1.0        -1.4      -1.2
Superoxide dismutase 1, soluble          -1.2        -1.2      -1.2
Guanidinoacetate methyltransferase       -1.2        -1.3      -1.0
[delta]3, [delta]2-enoyl-CoA
  isomerase                              -1.2        -1.2      -1.3
APP-binding protein 1                    -1.2        -1.6      -1.1
ESTs, similar to heat shock 10 kDa
  protein 1                              -1.2        -1.3      -1.6
Adrenodoxin reductase                    -1.1        -1.5      -1.1
Splicing factor YT521-B                  -1.1        -1.2      -1.2
Prolactin receptor                        1.0        -1.3      -1.2
ESTs, similar to guanylate cyclase       -1.2        -1.3      -1.1
  1, soluble, [alpha]-3
Mitochondrial 3-hydroxy-3-
  methylglutaryl-CoA synthase            -1.2        -1.6      -1.3
Phosphatidylethanolamine binding
  protein                                -1.2        -1.3      -1.2
ESTs, similar to follistatin             -1.3        -1.5      -1.1
Follicle-stimulating hormone
  receptor                                 A          A          A
Glutathione-S-transferase, [mu]
  type 1 (Yb1)                           -1.2        -1.4      -1.2
Inhibitor of DNA binding 1,
  helix-loop-helix protein                1.0        -1.1       1.0
Adrenodoxin reductase                     1.0        -1.4      -1.2
Growth factor receptor bound protein
  14                                     -1.5        -1.8      -1.3
Mitochondrial 3-hydroxy-3-
  methylglutaryl-CoA synthase            -1.3        -2.0      -1.6
Follistatin                              -1.3        -1.4      -1.3
Glutathione transferase subunit 8        -1.2        -1.5      -1.3
FST219344 Rattus norvegicus              -1.2        -1.7      -1.4
Glutathione-S-transferase, [mu] type
  2 (Yb2)                                -1.2        -1.2      -1.1
Glutathione-S-transferase, [mu] type
   2 (Yb2)                               -1.1        -1.3      -1.2
Gonadotropin-releasing hormone
  receptor                               -1.1        -1.8      -1.4
Inhibin [alpha]                          -1.2        -1.6      -1.6
Heat shock protein 60 (liver)            -1.3        -1.3      -1.6
ESTs                                     -1.2        -1.4      -1.4
Minoxidil sulfotransferase               -1.2        -1.4      -1.4
Glutathione-S-transferase, [alpha]
  type (Ya)                              -1.2        -1.5      -1.4
Aldehyde dehydrogenase 1, subfamily
  A1                                      1.1        -1.5      -1.5
Hydroxysteroid dehydrogenase
  17[beta] type 1                        -1.5        -2.3      -1.6
Inhibitor of DNA binding 3, dominant
  negative helix-loop-helix              -1.2        -1.3      -1.1
EST217223 Rattus norvegicus,
  identical to inhibitor of DNA
  binding 3, dominant negative
  helix-loop-helix                       -1.4        -1.4      -1.1
Delta-like homolog (Drosophila), a
  novel member of the epidermal
  growth factor (EGF)-like family of
  proteins                                 A          A          A
3 [beta]-Hydroxysteroid
  dehydrogenase isomerase type II        -1.1        -1.4      -1.6
Type II cAMP-dependent protein
  kinase regulatory subunit              -1.3        -1.9      -1.8
Glutathione S-transferase Yc1
  subunit                                -1.2        -1.5      -1.6
Mismatch repair protein                  -1.1        -1.5      -1.1
Sialoprotein (osteopontin)                1.0        -3.5      -2.4
SVS-protein F, or seminal vesicle
  secretion 5                            -1.4        -3.9       1.1
Cytochrome P450, subfamily XVII           1.1        -2.4      -2.2

A, absent (undetectable by Microarray Suite 5.0; Affymetrix).
Transcripts listed are those previously reported to show a robust
response to graded doses of EE in the uterotrophic assay (p < 0.001)
(Naciff et al. 2003); n = 5 per group.

(a) From GenBank (2004). (b) The average fold change is the ratio
of the relative expression level of each gene in uterus/ovaries from
animals fed Purina 5001 versus those fed 5K96 diet (n = 5 per group).

Table 5. Selected gene expression changes verified by QRT-PCR.

                                                 CC3          icabp

Treatment                                     Q      M      Q     M

Vehicle in Purina 5001 vs. 5K96               1.0    A     1.2   1.1
0.1 EE [micro]g vs. control in 5K96          18.7   14.7   3.7   5.2
0.1 FF [micro]g vs. control in Purina 5001   21.2    7.0   3.3   2.1

                                             11[beta]
                                               HSD          PgR

Treatment                                     Q     M     Q     M

Vehicle in Purina 5001 vs. 5K96              1.2   1.0   1.1   1.1
0.1 EE [micro]g vs. control in 5K96          2.7   2.2   1.8   1.6
0.1 FF [micro]g vs. control in Purina 5001   2.9   1.6   2.2   1.5

                                                EST
                                             AA924772    VaACTIN

Treatment                                     Q     M    Q     M

Vehicle in Purina 5001 vs. 5K96              -1.1   A   1.2   1.1
0.1 EE [micro]g vs. control in 5K96          -1.5   A   1.1   1.0
0.1 FF [micro]g vs. control in Purina 5001   -1.4   A   1.1   1.1

                                             Cyp17         Cyclo B

Treatment                                     Q      M      Q     M

Vehicle in Purina 5001 vs. 5K96              -1.2    1.1   1.1   1.0
0.1 EE [micro]g vs. control in 5K96          -3.5   -2.4   1.0   1.1
0.1 FF [micro]g vs. control in Purina 5001   -3.4   -2.2   1.1   1.0

Abbreviations: 11[beta]HSD, 11-[beta]-hydroxylsteroid dehydrogenase
type 2 gene; A, absent (undetectable by Microarray Suite 5.0;
Affymetrix); cyclo B, cyclophilin B gene; Cyp17, cytochrome P450
subfamily XVII gene; M, microarray-derived fold change; Q,
QRT-PCR-derived fold change; VaACTIN, vascular [alpha]-actin gene.
The relative fold change is the ratio of the relative expression level
of each gene in uterus/ovaries from animals fed Purina 5001 versus
those fed 5K96 diet. The microarray-derived fold change and the
QRT-PCR-derived fold change were determined as described in "Materials
and Methods," using the same amount of total RNA derived from three
independent animals, in duplicate. These genes were chosen on the
basis of their response to estrogenic stimulation in the uterotrophic
assay (Naciff et al. 2003); we also included two control genes, cycle
B and VaACTIN.

REFERENCES

Affymetrix Inc. 2002. Affymetrix Data Mining Tool (DMT), Version 3.0. Available: http://vwwv.affymetrix.com/support/technical/ datasheets/dmt_datasheet.pdf. [accessed 21 June 2004].

Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, et al. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.

Anthony MS, Clarkson TB, Hughes CL Jr, Morgan TM, Burke GL 1996. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126:43-50.

Arora A, Nair MG, Strasburg GM. 1998. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys 356:133-141.

Ashby J. 2000. Getting the problem of endocrine disruption into focus: the need for a pause for thought. APMIS 108:805-813.

Beck V, Unterrieder E, Krenn L, Kubelka W, Jungbauer A. 2003. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J Steroid Biochem Mol Biol 84:259-268.

Bereziat V, Kasus-Jacobi A, Perdereau D, Cariou B, Girard J, Burnol AF. 2002. Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14. J Biol Chem 277:4845-4852.

Boettger-Tong H, Murthy L, Chiappetta C, Kirkland JL, Goodwin B, Adlercreutz H, et al. 1998. A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ Health Perspect 106:369-373.

Boue SM, Wiese TE, Nehls S, Burow ME, Elliott S, Carter-Wientjes CH, et al. 2003. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. J Agric Food Chem 51:2193-2199.

Brown NM, Setchell KD, 2001. Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones. Lab Invest 81:735-747.

Casanova M, You L Gaido KW, Archibeque-Engle S, Janszen DB, Heck HA. 1998. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro. Toxicol Sci 51:236-244.

Dean NM, Kanemitsu M, Boynton AL. 1989. Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T51B cells. Biochem Biophys Res Commun 165:795-801.

Degen GH, Janning P, Diel P, Bolt HM. 2002, Estrogenic isoflavones in rodent diets. Toxicol Lett 128:145-147.

Duarte J, Ocete MA, Perez-Vizcaino F, Zarzuelo A, Tamargo J, 1997. Effect of tyrosine kinase and tyrosine phosphatase inhibitors on aortic contraction and induction of nitric oxide synthase. Eur J Pharmacol 338:25-33.

Foth D, Cline JM. 1998. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am J Clin Nutr 68(6 suppl):1413S-1417S.

GenBank. 2004. GenBank Overview. Bethesda, MD:National Center for Biotechnology Information, National Library of Medicine. Available: http://www.ncbi.nlm.nih.gov/Genbank/ GenbankOverview.html [accessed 1 October 2004].

Heikaus S, Winterhager E, Traub O, Grummer R. 2002. Responsiveness of endometrial genes connexin26, connexin43, C3 and clusterin to primary estrogen, selective estrogen receptor modulators, phyto- and xenoestrogens. J Mol Endocrinol 29:239-249.

Huang XF, Luu-The V. 2000. Molecular characterization of a first human 3(alpha [right arrow] beta)-hydroxysteroid epimerase. J Biol Chem 275:29452-29457.

Institute of Laboratory Animal Resources. 1996. Guide for the Care and Use of Laboratory Animals. 7th ed. Washington, DC:National Academy Press.

Jefferson WN, Padilla-Banks E, Clark G, Newbold RR. 2002. Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J Chromatogr B Analyt Technol Biomed Life Sci 777:179-189.

Kang SK, Choi KC, Yang HS, Leung PC. 2003. Potential role of gonadotrophin-releasing hormone (BnRH)-I and GnRH-II in the ovary and ovarian cancer. Endocr Relat Cancer 10:169-177.

Kanno J, Kate H, Iwato T, Inoue T. 2002. Phytoestrogen-low diet for endocrine disruptor studies. J Agric Food Chem 50:3883-3885.

Kasus-Jacobi A, Perdereau D, Auzan C, Clauser E, Van Obberghen E, Mauvais-Jarvis F, et al. 1998. Identification of the rat adapter Grb14 as an inhibitor of insulin actions. J Bid Chem 273:26026-26035.

Krisinger J, Dann JL, Currie WD, Jeung EB, Leung PC. 1982. Calbindin-D9k mRNA is tightly regulated during the estrous cycle in the rat uterus. Mol Cell Endocrinol 86:119-123.

Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870.

Kuiper GG, Lemmon JG, Carlsson B, Carton JC, Safe SH, van der Saag PT, et al. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:4252-4263.

Levy JR, Faber KA, Awash L, Hughes CL Jr. 1995. The effect of prenatal exposure to the phytoestrogen genistein on sexual differentiation in rats. Proc Soc Exp Biol Med 208:60-66.

L'Horset F, Perret C, Brehier A, Thomasset M. 1980. 17 Beta-estradiol stimulates the calbindin-D9k (CaBP9k) gene expression at the transcriptional and posttranscriptional levels in the rat uterus. Endocrinology 127:2891-2897.

Li SH, Huang HL, Chen YH. 2002. Ovarian steroid-regulated synthesis and secretion of complement C3 and factor B in mouse endometrium during the natural estrous cycle and pregnancy period. Biol Reprod 66:322-332.

Li XJ, Yu HM, Koide SS. 1997. Regulation of water channel gene (AQP-CHIP) expression by estradiol and anordiol in rat uterus [in Chinese]. Yao Xue Xue Bee 32:586-592.

Lockhart DJ, Dung H, Byrne MC, Follettie MT, Gallo MV, Chee MS, et al. 1996. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14:1675-1680.

Naciff JM, Jump ML, Torontali SM, Carr GJ, Tiesman JP, Overmann GJ, et al. 2002. Gene expression profile induced by 17alpha-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol Sci 68:184-199.

Naciff JM, Overmann GJ, Torontali SM, Carr GJ, Tiesman JP, Richardson BD, et al. 2003. Gene expression profile induced by 17 alpha-ethynyl estradiol in the prepubertal female reproductive system of the rat. Toxicol Sci 72214-330.

Odum J, Tinwell H, Jones K, Van Miller JP, Joiner RL, Tobin G, et al. 2001. Effect of rodent diets on the sexual development of the rat. Toxicol Sci 61:115-127.

OECD. 2001. Detailed Review Paper. Appraisal of Test Methods for Sex Hormone Disrupting Chemicals, 0ECD Monograph No 21. Paris:Organisation of Economic Co-operation and Development, Available: http://www.oecd.org/dataoecd/ 47/21/2074124.pdf [accessed 1 October 2004].

Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. 1988. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 157:183-189.

Owens W, Ashby J, Odum J, Onyon L. 2003. The OECD program to validate the rat uterotrophic bioassay. Phase 2: dietary phytoestrogen analyses. Environ Health Perspect 111:1559-1567.

Potier B, Rovira C. 1999. Protein tyrosine kinase inhibitors reduce high-voltage activating calcium currents in CA1 pyramidal neurones from rat hippocampal slices. Brain Res 816:587-597.

Richard C, Gas J, Brown N, Reese J. 2003. Aquaporin water channel genes are differentially expressed and regulated by ovarian steroids during the periimplantation period in the mouse. Endocrinology 144:1533-1541.

Sate T, Wang G, Hardy MP, Kurita T, Cunha GR, Cooke PS. 2002. Role of systemic and local IGF-1 in the effects of estrogen on growth and epithelial proliferation of mouse uterus, Endocrinology 143:2673-2679.

Thigpen JE, Li LA, Richter CB, Lebetkin EH, Jameson CW. 1997. The mouse bioassay for the detection of estrogenic activity in rodent diets: IL Comparative estrogenic activity of purified, certified and standard open and closed formula rodent diets. Lab Anita Sci 37:602-505.

Thigpen JE, Haseman JK, Saunders H, Locklear J, Caviness G, Grant M, et al. 2002. Dietary factors affecting uterine weights of immature CD-1 mice used in uterotrophic biosssays. Cancer Detect Prey 26:381-393.

Thigpen JE, Setchell KD, Ahlmark KB, Locklear J, Spahr T, Caviness GF, et al. 1999. Phytoestrogen content of purified, open- and closed-formula laboratory animal diets. Lab Anim Sci 49:530-536.

U.S. EPA. 1998. Chapter 5: Screening and Testing. In: Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) Final Report. Washington, DC:U.S. Environmental Protection Agency, 5-1-5-91. Available: http://www..:gov/ scipoly/osependo/docs/adstac/chap5v14.pdf [accessed 22 June 2004].

Wade MG, Lee A, McMahon A, Cooke G, Curran I. 2003. The influence of dietary isoflavone on the uterotrophic response in juvenile rats. Food Chem Taxicol 41:1517-1525.

Yamasaki K, Sawaki M, Noda S, Wada T, Hare T, Takatsuki M. 2002. Immature uterotrophic assay of estrogenic compounds in rats given diets of different phytoestrogen content and the ovarian changes with ICI 182,780 or antide. Arch Toxicol 76:613-620.

Jorge M. Naciff, Gary J. Overmann, Suzanne M. Torontali, Gregory J. Carr, Jay P. Tiesman, and George P. Daston Miami Valley Laboratories, The Procter and Gamble Company, Cincinnati, Ohio, USA

Address correspondence to J.M. Naciff, The Procter and Gamble Company, Miami Valley Laboratories, P.O. Box 538707 #805, Cincinnati, OH 45253-8707 USA. Telephone: [phone]. Fax: [phone]. E-mail: [e-mail]

We thank C. Ryan and W. Owens for their helpful discussions.

The authors are employed by the Procter and Gamble Company.

Received 10 November 2003; accepted 16 August 2004.